Ravindra Uppaluri MD PhD
Head & Neck Oncologic Surgery
Director, Head and Neck Surgical Oncology, Chief, Division of Otolaryngology Dana-Farber Cancer Institute / Brigham and Women's Hospital
Join to View Full Profile
45 Francis StreetBoston, MA 02115
Phone+1 617-525-3000
Dr. Uppaluri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 1996 - 2001- Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 1996 - 2000
- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1995 - 1996
University of Minnesota Medical SchoolClass of 1995
Certifications & Licensure
MA State Medical License 2016 - 2026
MO State Medical License 1996 - 2017
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Clinical Trials
- GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Start of enrollment: 2013 Feb 01
- Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer Start of enrollment: 2013 Jan 10
- Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma Start of enrollment: 2015 Mar 25
Publications & Presentations
PubMed
- Easing cisplatin's toll in nasopharyngeal carcinoma.Michael J Dennis, Ravindra Uppaluri
Cancer Cell. 2025-05-12 - Mixing it up: boosting responses with immunotherapy combinations.Hiroki Komatsuda, Edward S Sim, Ravindra Uppaluri
Trends in Cancer. 2025-05-06 - 4 citationsA Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller, Bethany Sargent, Evan Carey
Clinical Cancer Research. 2025-05-01
Journal Articles
- A Deep Learning Approach to Automate Refinement of Somatic Variant Calling from Cancer Sequencing DataRavindra Uppaluri, Gavin P Dunn, Ramaswamy Govindan, S Joshua Swamidass, Todd A Fehniger, Nature
- Tumor Innate Immunity Primed by Specific Interferon-Stimulated Endogenous RetrovirusesScott Rodig, Ewa Sicinska, Thanh Uyen Barbie, David Allen Barbie, Russell William Jenkins, Ravindra Uppaluri, Rohit Thummalapalli, Jacob Sands, Nature
Press Mentions
FDA Approves Immune Checkpoint Inhibitor Drug for Patients with Resectable Locally Advanced Head and Neck Cancer, Backed by Dana-Farber ResearchJune 13th, 2025- FDA OKs Perioperative Immunotherapy for Head and Neck CancerJune 13th, 2025
- American Association for Cancer Research, April 25-30May 8th, 2025
- Join now to see all
Grant Support
- IFN Gamma Induced Angiostatic ChemokinesNational Cancer Institute2002–2006
Professional Memberships
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
